Evolent Health, Inc. (EVH)
4.24
+0.01
(+0.24%)
USD |
NYSE |
Sep 03, 12:18
Evolent Health Cash from Investing (Quarterly) : -6.699M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.699M |
| March 31, 2026 | -6.406M |
| December 31, 2025 | 82.15M |
| September 30, 2025 | -8.762M |
| June 30, 2025 | -60.53M |
| March 31, 2025 | -13.09M |
| December 31, 2024 | -19.93M |
| September 30, 2024 | -19.73M |
| June 30, 2024 | -13.54M |
| March 31, 2024 | -9.732M |
| December 31, 2023 | -6.052M |
| September 30, 2023 | -6.145M |
| June 30, 2023 | -8.354M |
| March 31, 2023 | -394.99M |
| December 31, 2022 | -4.456M |
| September 30, 2022 | -254.99M |
| June 30, 2022 | -16.44M |
| March 31, 2022 | 16.77M |
| December 31, 2021 | -54.37M |
| September 30, 2021 | -1.798M |
| June 30, 2021 | -5.571M |
| March 31, 2021 | 45.95M |
| December 31, 2020 | -2.225M |
| September 30, 2020 | 281.68M |
| June 30, 2020 | -7.575M |
| Date | Value |
|---|---|
| March 31, 2020 | -10.81M |
| December 31, 2019 | -79.17M |
| September 30, 2019 | -11.64M |
| June 30, 2019 | -65.34M |
| March 31, 2019 | -25.48M |
| December 31, 2018 | -135.44M |
| September 30, 2018 | -5.557M |
| June 30, 2018 | -6.691M |
| March 31, 2018 | -12.68M |
| December 31, 2017 | -29.27M |
| September 30, 2017 | 15.66M |
| June 30, 2017 | -3.283M |
| March 31, 2017 | 4.622M |
| December 31, 2016 | -74.97M |
| September 30, 2016 | -4.357M |
| June 30, 2016 | -4.811M |
| March 31, 2016 | -13.66M |
| December 31, 2015 | -54.82M |
| September 30, 2015 | -4.915M |
| June 30, 2015 | 16.05M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DarioHealth Corp. | -2.287M |
| CompuMed, Inc. | 0.00 |
| Teladoc Health, Inc. | -41.59M |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | -17.89M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.312M |
| Cash from Financing (Quarterly) | -10.99M |
| Free Cash Flow | 24.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1436 |
| Free Cash Flow to Equity (Quarterly) | -1.17M |
| Free Cash Flow to Firm (Quarterly) | 2.483M |
| Free Cash Flow Yield | 5.10% |